OBSERVATIONS B-Type Natriuretic Peptide in Type 2 Diabetes

نویسندگان

  • CLARA VERDÚ
  • V. R. SALAZAR
  • J. ANTONIO RUIZ
  • JORGE SALES
  • Ma ISABEL LUCENA
  • RAÚL J. ANDRADE
چکیده

C ardiac ventricles release B-type natriuretic peptide (BNP) in response to volume expansion and pressure overload; therefore, BNP concentration may be used as a biochemical marker of cardiac failure (1). BNP levels are high in diabetic subjects with left ventricular dysfunction (2). Because the diagnosis of cardiac failure may be an emergency (3), it is important to know whether the timing of BNP measurement (before or after a meal) affects the result. The effect of renal failure is also an important practical issue, since 25–40% of diabetic subjects have diabetic nephropathy. This study was designed to describe the changes elicited by chronic renal failure (CRF) and meal consumption on BNP levels in diabetic patients. Thirty diabetic patients were divided into two groups: 15 patients without CRF (group 1: glomerular filtration rate [GFR]) by Cockcroft’s formula 60 ml/ min) and 15 patients with CRF (group 2: GFR 60 ml/min). No patient presented significant cardiac history based on clinical examination, electrocardiograph recording, and chest radiography. Four blood samples were collected before and 1, 2, and 3 h (T0 to T3) after a standardized meal (72 g carbohydrates, 21 g lipids, and 32 g proteins) to measure plasma BNP concentrations (IRMA ShionoriaBNP, Schering Cis Bio). Mean BNP levels ( SD) for the two groups were compared using the Mann-Whitney U test. Values for repeated data before and after lunch were compared by ANOVA. Sex, age, BMI, type of diabetes, HbA1c, and blood pressure were similar in the two groups. GFR was lower in group 2 (group 1: 92 20, group 2: 36 15 ml/min; P 0.001). No significant difference was found between BNP concentrations before and after lunch in both groups (group 1: T 12.3 23.1, T1 11.7 21.9, T2 12.3 21.9, T3 12.5 23.2 pg/ml; group 2: T 34.9 37.9, T1 34.7 38.9, T2 35.9 36.7, T3 35.7 39.4 pg/ml). The BNP concentrations were higher in group 2 (P 0.05 for each time). When the two groups were analyzed together, BNP concentrations were negatively correlated with GFR (r 0.56, P 0.005). Natriuretic peptides play many physiological roles; therefore, determining whether feeding affects BNP concentrations is a practical problem. Plasma -atrial natriuretic peptide concentrations are increased by feeding in nondiabetic subjects (4). We show here that feeding does not affect plasma BNP levels in diabetic patients; blood samples can be drawn at any time for BNP measurement. In nondiabetic patients, BNP distinguishes patients with a left ventricular hypertrophy and CRF (5). In our study, plasma BNP concentrations were higher in diabetic patients with CRF before and after feeding. Plasma BNP may therefore be used to monitor the cardiac function in diabetic subjects with CRF, but its reduced clearance participating in its increased concentrations needs to be taken into account.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The Association between B-type Natriuretic Peptide Family and Successful Percutaneous Transvenous Mitral Commissurotomy: A Systematic Review

B-type natriuretic peptide (BNP) level is known to increase in patients with rheumatic mitral stenosis. In this systematic review, we aimed to discuss the possible association between plasma BNP level and the success rate of percutaneous transvenous mitral commissurotomy. PubMed and Scopus databases were searched systematically, using the following key terms: “B-type natriuretic peptide” OR “BN...

متن کامل

Comparative assessment of N-terminal pro-B-type natriuretic peptide, nitric oxide and echocardiography for diagnosis of dilated cardiomyopathy in dogs

The aim of the study was to evaluate the clinical usefulness of N-terminal pro-brain natriuretic peptide (NT-Pro BNP) and nitric oxide (NO) with echocardiography (gold standard test) in diagnosis of canine cardiomyopathy. Out of 374 cases, 82 cases showing cardiovascular abnormalities including 16 cases of cardiomyopathy were further selected for standardization of biomarkers. Significant (P

متن کامل

Diagnostic Value of N Terminal Pro B Type Natriuretic Peptide (NT-pro BNP) in Cardiac Involvement in Patients with Beta- Thalassemia

Background Heart failure is a major cause of death in thalassemia. The study aimed to determine the diagnostic value of N Terminal Pro B Type Natriuretic Peptide (NT-pro BNP), to early diagnose the cardiac involvement in beta- thalassemia major patients. Materials and Methods  80 thalassemia patients aged 7 to 18 years old (patients group), and 80 healthy age and gender matched controls were ...

متن کامل

Clinical and Biochemical Assessments of Circulating B-Type Natriuretic Peptide as a Useful Marker in Pediatric Cardiac Patients

Background Although the left ventricle is the major site of BNP secretion in response to cardiac pressure or volume overload, the myocytes of both atria and ventricles secrete B- type natriuretic peptide (BNP). This study aimed to assess and compare the plasma levels of BNP in common pediatric cardiac diseases to clarify its pathophysiological role and evaluate its po...

متن کامل

Diagnostic and Prognostic Value of Cardiac Biomarkers in Children with Kawasaki Disease: A State-of-the-Art Review

      Kawasaki disease (KD) is characterized as the leading cause of acquired cardiac disease in children. Accurate and timely diagnosis of KD is of high importance for preventing its cardiac complications. However, diagnosis merely based on clinical findings has a number of challenges and, limitations. Therefore, researchers are investigating to find more object...

متن کامل

Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial.

BACKGROUND Diabetes mellitus and heart failure frequently coexist. However, few diabetes mellitus trials have prospectively evaluated and adjudicated heart failure as an end point. METHODS AND RESULTS A total of 16 492 patients with type 2 diabetes mellitus and a history of, or at risk of, cardiovascular events were randomized to saxagliptin or placebo (mean follow-up, 2.1 years). The primary...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2005